| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AI-based tumor-infiltrating lymphocyte scoring system for assessing HCC prognosis in patients undergoing liver resection
|
Chen, Zhiyang
|
|
|
7 |
2 |
p.
|
artikel
|
| 2 |
A patient-derived HCC spheroid system to model the tumor microenvironment and treatment response
|
Crouchet, Emilie
|
|
|
7 |
2 |
p.
|
artikel
|
| 3 |
Comparative evaluation of multimarker algorithms for early-stage HCC detection in multicenter prospective studies
|
Hou, Jinlin
|
|
|
7 |
2 |
p.
|
artikel
|
| 4 |
Contents
|
|
|
|
7 |
2 |
p.
|
artikel
|
| 5 |
Copyright and information
|
|
|
|
7 |
2 |
p.
|
artikel
|
| 6 |
Deep learning helps discriminate between autoimmune hepatitis and primary biliary cholangitis
|
Gerussi, Alessio
|
|
|
7 |
2 |
p.
|
artikel
|
| 7 |
Editorial Board page
|
|
|
|
7 |
2 |
p.
|
artikel
|
| 8 |
First-line chemotherapy with selective internal radiation therapy for intrahepatic cholangiocarcinoma: The French ACABi GERCOR PRONOBIL cohort
|
Adamus, Nicolas
|
|
|
7 |
2 |
p.
|
artikel
|
| 9 |
Lower incidence of hepatocellular carcinoma with tenofovir alafenamide in chronic hepatitis B: Evidence from a large-scale cohort
|
Yoo, Hye-Jin
|
|
|
7 |
2 |
p.
|
artikel
|
| 10 |
MetALD: Clinical aspects, pathophysiology and treatment
|
Gratacós-Ginès, Jordi
|
|
|
7 |
2 |
p.
|
artikel
|
| 11 |
Modeling challenges of hepatitis D virus kinetics during bulevirtide-based therapy
|
Mhlanga, Adquate
|
|
|
7 |
2 |
p.
|
artikel
|
| 12 |
Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinoma
|
Tabrizian, Parissa
|
|
|
7 |
2 |
p.
|
artikel
|
| 13 |
Progressive systemic inflammation precedes decompensation in compensated cirrhosis
|
Sánchez-Aldehuelo, Rubén
|
|
|
7 |
2 |
p.
|
artikel
|
| 14 |
Quo vadis autoimmune hepatitis? - Summary of the 5th international autoimmune hepatitis group research workshop 2024
|
Engel, Bastian
|
|
|
7 |
2 |
p.
|
artikel
|
| 15 |
Reply to: “Understanding virologic heterogeneity in chronic hepatitis B treatment”
|
Matthews, Philippa C.
|
|
|
7 |
2 |
p.
|
artikel
|
| 16 |
Risk of hepatocellular carcinoma in Asian patients with primary biliary cholangitis: A nationwide and hospital cohort study
|
Lim, Jihye
|
|
|
7 |
2 |
p.
|
artikel
|
| 17 |
Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab
|
Wu, Meng
|
|
|
7 |
2 |
p.
|
artikel
|
| 18 |
Sex differences in murine MASH induced by a fructose-palmitate-cholesterol-enriched diet
|
Arivazhagan, Lakshmi
|
|
|
7 |
2 |
p.
|
artikel
|
| 19 |
Understanding virologic heterogeneity in chronic hepatitis B treatment
|
Luo, Renqi
|
|
|
7 |
2 |
p.
|
artikel
|
Tijdschrift beschrijving